StockNews.com began coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a research note released on Sunday. The firm issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Stock Performance
Shares of CO opened at $1.25 on Friday. The stock has a market capitalization of $151.94 million, a PE ratio of 1.95 and a beta of 0.16. The company’s fifty day moving average is $1.44 and its 200 day moving average is $1.36. Global Cord Blood has a fifty-two week low of $2.03 and a fifty-two week high of $5.50.
Global Cord Blood Company Profile
Featured Articles
- Five stocks we like better than Global Cord Blood
- The How and Why of Investing in Biotech Stocks
- AMD is Down 35%. Now is the Time to Buy the Dip
- Where to Find Earnings Call Transcripts
- Amazon Stands Tall: New Highs Are in Sight
- How to Use the MarketBeat Stock Screener
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.